PAPER van Blitterswijk M, Gulati S, Smoot E, Jaffa M, Maher N, Hyman BT, Ivinson AJ, Scherzer CR, Schoenfeld DA, Cudkowicz ME, Brown RH, Bosco DA
SEARCH RESULTS
331254 RESULTS
PAPER Nandipati S, Luo X, Schimming C, Grossman HT, Sano M
Cognition in Non-Demented Diabetic Older Adults.
Curr Aging Sci. 2011 Oct 21; PubMed: 22023096PAPER Wostyn P, Van Dam D, Audenaert K, De Deyn PP
Genes involved in cerebrospinal fluid production as candidate genes for late-onset Alzheimer's disease: a hypothesis.
J Neurogenet. 2011 Dec;25(4):195-200. PubMed: 22023247PAPER Tao RR, Ji YL, Lu YM, Fukunaga K, Han F
Targeting nitrosative stress for neurovascular protection: New implications in brain diseases.
Curr Drug Targets. 2011 Oct 21; PubMed: 22023405PAPER Bolea I, Juárez-Jiménez J, de Los Rı́os C, Chioua M, Pouplana R, Luque FJ, Unzeta M, Marco-Contelles J, Samadi A
Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer's Di
J Med Chem. 2011 Dec 22;54(24):8251-8270. PubMed: 22023459PAPER Pluta R, Jolkkonen J, Cuzzocrea S, Pedata F, Cechetto D, Popa-Wagner A
Cognitive impairment with vascular impairment and degeneration.
Curr Neurovasc Res. 2011 Nov 1;8(4):342-50. PubMed: 22023618PAPER Fazil M, Shadab, Baboota S, Sahni JK, Ali J
Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.
J Drug Target. 2012 Feb;20(2):97-113. PubMed: 22023651PAPER Walker Z, Cummings JL
[(123)I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
Alzheimers Dement. 2012 Jan;8(1):74-83. PubMed: 22024052PAPER Yao J, Rettberg JR, Klosinski LP, Cadenas E, Brinton RD
Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
Mol Aspects Med. 2011 Aug;32(4-6):247-57. PubMed: 22024249PAPER Beckett C, Nalivaeva NN, Belyaev ND, Turner AJ
Nuclear signalling by membrane protein intracellular domains: the AICD enigma.
Cell Signal. 2012 Feb;24(2):402-9. PubMed: 22024280PAPER Duff K, Lyketsos CG, Beglinger LJ, Chelune G, Moser DJ, Arndt S, Schultz SK, Paulsen JS, Petersen RC, McCaffrey RJ
Practice effects predict cognitive outcome in amnestic mild cognitive impairment.
Am J Geriatr Psychiatry. 2011 Nov;19(11):932-9. PubMed: 22024617PAPER Hanfelt JJ, Wuu J, Sollinger AB, Greenaway MC, Lah JJ, Levey AI, Goldstein FC
An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the national Alzheimer's coordinating center.
Am J Geriatr Psychiatry. 2011 Nov;19(11):940-50. PubMed: 22024618PAPER Duff K, Chelune GJ, Dennett K
Predicting estimates of premorbid memory functioning: validation in a dementia sample.
Arch Clin Neuropsychol. 2011 Dec;26(8):701-5. PubMed: 22024960PAPER Vardy ER, Kellett KA, Cocklin SL, Hooper NM
Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease.
Neurodegener Dis. 2012;9(1):31-7. PubMed: 22024719PAPER Salek Y, Anderson ND, Sergio L
Mild cognitive impairment is associated with impaired visual-motor planning when visual stimuli and actions are incongruent.
Eur Neurol. 2011;66(5):283-93. PubMed: 22025035Current Filters
No filters selected